TrialThe Lancet. Respiratory medicine2024

First-line penpulimab combined with paclitaxel and carboplatin for metastatic squamous non-small-cell lung cancer in China (AK105-302): a multicentre, randomised, double-blind, placebo-controlled phase 3 clinical trial.

Hua Zhong et al.PubMed ↗Publisher ↗

No numbers read from the abstract.